DODominika Orłowska

Dominika Orłowska

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dominika Orłowska has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Use of Doppler Ultrasound in Perinatal Care: Maternal and Neonatal Care

    by Karolina Zalewa, Joanna Olszak, Marta Kaus, Dominika Orłowska, Lidia Bartoszek, Mikołaj Poleszczuk, Karol Poleszczuk, Anna Czuba, Alicja Milewska, Natalia Klepacz

    Introduction and purpose Doppler ultrasound has become a milestone in monitoring maternal and fetal health, offering critical information about blood flow in the placenta, umbilical cord, and fetal organs. Its applications range from assessing placental function to diagnosing complications such as fetal growth restriction, preeclampsia, and fetal anemia. Material and methods This review is based on articles from the PubMed database, published between 2015 and 2024, using keywords such as doppler USG, doppler ultrasound, doppler USG in perinatal care, doppler USG in neonatal care. Results Doppler ultrasound is a very effective and minimally invasive test that detects many pathologies in the perinatal and neonatal period. It allows for early diagnosis of many vascular pathologies, which allows for early treatment Conclusions Doppler ultrasound should be a commonly used test in perinatal and neonatal care. This would avoid some of the complications of these periods, improving survival, and financially relieve the health care system.

  • Open Access

    Deep Brain Stimulation in the treatment of disorders of consciousness

    by Joanna Olszak, Karolina Zalewa, Lidia Bartoszek, Dominika Orłowska, Wojciech Kapłan, Mikołaj Poleszczuk, Karol Poleszczuk, Alicja Milewska, Anna Czuba, Marta Kaus

    Introduction and Purpose Disorders of consciousness, such as the vegetative state (VS) and minimally conscious state (MCS), are significant neurological conditions where patients exhibit limited or no awareness of their surroundings. Despite advancements in medical care, treatment options for these conditions remain limited, and prognosis is often poor. Deep brain stimulation (DBS) has emerged as a promising therapeutic option, particularly for patients with MCS or severe brain injuries. This review explores the clinical applications, and outcomes of DBS in the treatment of disorders of consciousness. Material and Methods A comprehensive literature review was conducted using the PubMed database, focusing on articles published up to the end of 2024. The search included the keywords "deep brain stimulation", "disorders of consciousness", "neuromodulation therapy", and " effectiveness" in various combinations. Relevant studies were selected based on criteria such as the effect of DBS in patients with disorders of consciousness. Results Several studies have shown that DBS, particularly targeting regions such as the thalamus or subthalamicnucleus, can lead to improvements in consciousness levels, responsiveness to external stimuli, and interaction with the environment. In some cases, patients in MCS have exhibited improved awareness, motor responses, and even the ability to communicate. Key factors influencing outcomes include the timing of DBS application, the extent of brain injury, and the specific brain regions targeted. Conclusions DBS offers a novel and potentially effective treatment for patients with disorders of consciousness, especially those in a minimally conscious state. While the results are promising, more controlled and larger-scale clinical trials areneeded to better understand the long-term efficacy, optimal timing, and appropriate patient selection.

  • Open Access

    Application of Artificial Intelligence in Radiological Image Analysis for Pulmonary Disease Diagnosis: A Review of Current Methods and Challenges

    by Karolina Zalewa, Joanna Olszak, Wojciech Kapłan, Dominika Orłowska, Lidia Bartoszek, Marta Kaus, Natalia Klepacz

    Introduction and purposeArtificial intelligence (AI), particularly machine learning (ML) and deep learning (DL), is revolutionizing radiology by improving diagnostic accuracy and efficiency. This paper examines AI applications, especially convolutional neural networks (CNNs), in diagnosing pulmonary diseases, such as pneumonia, tuberculosis, and lung cancer. The goal is to explore the impact of these technologies and assess challenges in their integration into clinical practice. Material and methodsThis review is based on articles from the PubMed database, published between 2015 and 2024, using keywords such as artificial intelligence in radiology, AI in medicine, AI in chest X-ray, and AI in chest-CT. ResultsAI, driven by ML and DL, has significantly enhanced medical imaging analysis, automating tasks that require expert interpretation. CNNs excel in processing raw image data and identifying hierarchical features, surpassing traditional methods in diagnosing lung diseases from radiographs and CT scans. AI systems demonstrate exceptional accuracy in detecting pneumonia, tuberculosis, and lung cancer, providing rapid, consistent results, particularly valuable in resource-limited settings. However, challenges persist, including the need for diverse training datasets, model interpretability, and integration into existing workflows. ConclusionsAI, especially CNN-based DL models, is reshaping radiology by advancing diagnostic capabilities. While it often outperforms traditional methods, AI is best used to complement human expertise. Overcoming challenges in data quality, system integration, and training is essential for broader clinical adoption. Continued research will enhance AI’s reliability and utility, ultimately improving patient outcomes.


  • Open Access

    Complications after endoscopic spine surgery - risk factors and preventive strategies

    by Joanna Olszak, Karolina Zalewa, Lidia Bartoszek, Dominika Orłowska, Wojciech Kapłan, Mikołaj Poleszczuk, Karol Poleszczuk, Alicja Milewska, Anna Czuba

    Introduction and Purpose Endoscopic spine surgery (EOS) is a minimally invasive alternative to traditional surgery, with less tissue trauma and shorter hospital stay. Despite these advantages, these procedures are associated with the risk of complications. The aim of this article is to analyze the most common complications, identify risk factors, and discuss preventive strategies that can minimize the risk of their occurrence. Materials and Methods A comprehensive literature review was conducted using the PubMed database, focusing on articles published up to the end of 2024. The search included the keywords “endoscopic”, “spine surgery”, “complications”, and “risk factors” in different combinations. Relevant studies were selected based on criteria such as complications after endoscopic spine procedures and risk factors that affect them, as well as methods for their prevention. Results The literature review indicates that the most common complications after EOS are dura tears, nerve injury, infection, bleeding, and adhesions. Risk factors include both patient-related aspects and surgical technique. Patient factors include age, comorbidities, and anatomical abnormalities of the spine. Procedural factors include operator inexperience, selection of an inappropriate surgical approach, and technical limitations of endoscopic equipment. Conclusions Prevention of complications after EOS requires a comprehensive approach that includes both careful patient qualification and optimization of surgical technique. Regular operator training can significantly improve patient outcomes. Strict control of risk factors and individualization of the surgical approach are also key. These measures can not only reduce the risk of complications but also improve the efficiency and safety of endoscopic spine surgery.


  • Open Access

    Ultrasonography in the Diagnosis of Bronchiolitis: Evaluation of Effectiveness and Application in Clinical Practice

    by Karolina Zalewa, Joanna Olszak, Wojciech Kapłan, Dominika Orłowska, Lidia Bartoszek, Mikołaj Poleszczuk, Karol Poleszczuk, Anna Czuba, Alicja Milewska

    Introduction and Purpose This study investigates the effectiveness and clinical applicability of lung ultrasound (LUS) in diagnosing acute bronchiolitis. Bronchiolitis is challenging to diagnose due to symptom overlap with other respiratory infections and varying clinical presentations. While conventional diagnosis relies on patient history and physical examination, LUS has emerged as a promising, non-invasive tool that may improve diagnostic accuracy and provide valuable insights into disease severity without the radiation risks associated with X-rays. Material and MethodsThis review is based on articles from the PubMed database, covering the years 2012-2024, using keywords: bronchiolitis, LUS, lung ultrasound. ResultsThe study found that LUS demonstrated high sensitivity and specificity for identifying bronchiolitis-related lung abnormalities, including areas of consolidation and interstitial involvement. A strong association was observed between ultrasound scores and clinical severity, with elevated scores correlating with increased need for respiratory support. LUS was more effective than conventional chest X-rays for detecting consolidations over 1 cm and predicting oxygenation issues in critically ill patients. ConclusionsLUS proves to be a valuable diagnostic tool for bronchiolitis, providing a safe, radiation-free alternative to traditional imaging and yielding reliable information on disease severity. Its ease of use, combined with its predictive value in identifying children at risk for respiratory complications, highlights LUS as a practical method for bedside assessment. Moreover, advancements in AI-supported LUS analysis hold potential for reducing operator dependency, enhancing diagnostic consistency, and improving workflow efficiency in emergency settings. Integrating LUS into routine practice could thus enhance care for pediatric bronchiolitis patients, supporting more accurate, timely diagnoses and targeted treatment interventions.


  • Open Access

    Phantom pain - etiopathogenesis and treatment methods

    by Joanna Olszak, Karolina Zalewa, Lidia Bartoszek, Dominika Orłowska, Wojciech Kapłan, Mikołaj Poleszczuk, Anna Czuba, Karol Poleszczuk, Alicja Milewska

    Introduction and Purpose Phantom limb pain (PLP) is a complex and multifactorial phenomenon that arises following limb amputation, affecting a significant number of patients. This study aims to explore the underlying mechanisms of PLP, assess current treatment strategies, and evaluate the effectiveness of various therapeutic interventions, including pharmacological and non-pharmacological approaches. Material and Methods A comprehensive literature review was conducted using the PubMed database, focusing on articles published up to the end of 2023. The search included the keywords: "amputation", "mirror therapy", "pain", "phantom limb", "amputation-induced pain", "chronic pain" in various combinations. Relevant studies were selected based on criteria such as the etiopathogenesis of phantom pain and its treatment methods. Results The findings indicate that PLP is associated with both peripheral and central nervous system changes, influenced by individual risk factors such as genetics and psychological state. Therapeutic interventions such as mirror therapy, graded motor imagery, and neuromodulation have shown promise in alleviating symptoms, although the evidence for their effectiveness remains variable. The implementation of a multidisciplinary approach significantly improves outcomes in managing PLP. Conclusions Effective management of phantom limb pain requires a comprehensive understanding of its etiology and a tailored treatment strategy that incorporates both pharmacological and non-pharmacological methods. Future research should focus on establishing robust clinical protocols and long-term efficacy studies to enhance the quality of life for individuals suffering from PLP.


  • Open Access

    Somatic and psychiatric symptoms of brain tumors - a review of the literature

    by Joanna Olszak, Karolina Zalewa, Dominika Orłowska, Lidia Bartoszek, Wojciech Kapłan, Karol Poleszczuk, Mikołaj Poleszczuk, Alicja Milewska, Anna Czuba

    Introduction and Purpose Brain tumors cause a variety of somatic and psychiatric symptoms, which vary depending on the age of the patient and the location and type of tumor. Symptomatology includes both physical symptoms, such as headache, nausea, seizures and weakness, and psychiatric symptoms, including mood, personality and cognitive dysfunction. In children, the clinical picture is more complex and includes specific developmental difficulties. The purpose of this paper is to analyze the various symptoms accompanying brain tumors in order to detect them early and enable faster diagnosis. Material and Methods A comprehensive literature review was conducted using the PubMed database, focusing on articles published until the end of 2023.The search included the keywords: "brain tumors" "symptoms" "headache" and "psychiatric" in various combinations. Relevant studies were selected based on criteria such as somatic and psychiatric symptoms and early diagnosis of brain tumors. Results Accumulating data show the diversity of symptoms associated with brain tumors. Somatic symptoms such as headache, optic disc swelling, nausea, and seizures depend on intracranial pressure and tumor location. Psychiatric symptoms, including personality changes, mood disorders, and cognitive impairment, pose a significant diagnostic challenge in adult patients. In children, brain tumors can cause developmental delay and atypical neurological symptoms. Conclusions The symptoms of brain tumors are highly variable and difficult to diagnose, which significantly delays proper diagnosis of the disease. Its early detection is crucial as it improves the prognosis of patients, significantly improves their quality of life, and allows for the introduction of effective therapeutic interventions.


  • Open Access

    Drugs and other substances aggravating acne vulgaris

    by Karolina Zalewa, Joanna Olszak, Wojciech Kapłan, Dominika Orłowska, Lidia Bartoszek

    Introduction and Purpose This review explores several factors exacerbating acne, including the supplementation of vitamins B6 and B12, the impact of red ginseng oil, dairy and whey product consumption, iodine association, anabolic-androgenic steroids, alcohol abuse, and the influence of progestin contraceptives. Material and methods This review is based on articles from the PubMed database, covering the years 2018-2023, using keywords: acne vulgaris, acne vulgaris aggravation, substances aggravating acne vulgaris. Results High doses of B6 and B12 have been reported to worsen acne, potentially linked to their prolonged use. Red ginseng oil, believed to have numerous health benefits, may exacerbate acne symptoms by increasing inflammatory biomarkers. Dairy consumption, specifically casein and whey proteins, is associated with increased insulin-like growth factor 1, contributing to acne aggravation. Iodine has been extensively linked to acneiform eruptions, and its correlation with dairy consumption is hypothesized. Anabolic-androgenic steroids, found in muscle-building supplements, elevate sebum production and may cause acne fulminans. Alcohol abuse further intensifies acne symptoms by impacting testosterone levels, promoting proinflammatory cytokine production, and altering the skin microbiome. Progestin contraceptives, particularly levonorgestrel and etonorgestrel, exhibit androgenic properties that may increase sebum production and potentially aggravate acne. Conclusions Understanding and identifying these exacerbating factors are crucial for healthcare providers to enhance anti-acne therapy outcomes, emphasizing the importance of not only treating but also preventing the escalation of acne manifestations in patients.

  • Open Access

    The role of vitamin D in the development and prevention of migraine: a review

    by Joanna Olszak, Karolina Zalewa, Wojciech Kapłan, Dominika Orłowska, Lidia Bartoszek

    Introduction and Purpose Migraine is a widespread neurological disorder characterized by severe, pulsating headaches often accompanied by nausea, vomiting, and hypersensitivity to light and sound. Although its exact cause is still under investigation, recent studies suggest that vitamin D deficiency may play a role in migraine occurrence and severity. Vitamin D, known primarily for its role in bone health, also affects the nervous and immune systems, and may influence inflammatory processes involved in migraine pathogenesis. This literature review aims to explore the relationship between vitamin D supplementation and the frequency and intensity of migraines, and whether supplementation could support migraine treatment. Material and Methods A comprehensive literature review was conducted using the PubMed database, focusing on articles published until the end of 2023. The search included the keywords: "vitamin D," "migraine," "headache," and "supplementation" in various combinations. Relevant studies were selected based on criteria such as monitoring vitamin D levels and the use of supplementation as an intervention in migraine patients. Results The results of the review suggest that vitamin D deficiency may be associated with an increased frequency of migraines. Supplementation with vitamin D was linked to a reduction in both the frequency and severity of migraines. While not all studies were consistent, the majority indicated that supplementation had a positive impact, particularly in individuals with vitamin D deficiency. Conclusions The findings suggest that vitamin D deficiency could be a risk factor for migraines, and that supplementation with vitamin D may help reduce the severity and frequency of migraine attacks. Although further research is required to establish optimal dosages and treatment protocols, vitamin D supplementation shows promise as a supportive therapy in migraine management.

  • Open Access

    Consumption of cranberry and probiotics as a natural remedy for urinary tract infections

    by Dominika Orłowska, Karolina Zalewa, Joanna Olszak, Lidia Bartoszek, Wojciech Kapłan

    Introduction and PurposeUrinary tract infections (UTIs) are a prevalent health issue caused primarily by uropathogenic Escherichia coli (UPEC) and other pathogens, affecting millions annually. These infections encompass lower (cystitis) and upper (pyelonephritis) tract manifestations, presenting with symptoms ranging from dysuria to severe complications like sepsis. Traditional antibiotic treatments, while effective, are increasingly challenged by resistance and adverse effects, necessitating exploration of alternative therapies. Cranberry-derived compounds, particularly proanthocyanidins (PACs), are known for their ability to inhibit bacterial adhesion to uroepithelial cells, a critical step in UTI pathogenesis. Clinical studies suggest that cranberry products may reduce UTI incidence, especially in vulnerable populations such as women and catheterized patients. Probiotics, specifically lactobacilli, contribute to urogenital health by competing with uropathogens for epithelial cell binding sites and producing antimicrobial substances. Emerging research highlights the potential synergistic benefits of combining cranberry extracts with probiotics in UTI prevention strategies. Material and MethodsThis review is based on articles from the PubMed database, covering the years 2004-2023, using keywords: urinary tract infections, cranberry, probiotics, E. Coli, antibiotics ConclusionsCranberry products and probiotics offer promising non-antibiotic approaches for UTI prevention, targeting fundamental aspects of bacterial pathogenesis. While preliminary studies indicate promising outcomes, rigorous clinical trials are essential to validate these combinations and optimize therapeutic protocols. Further research is warranted to identify specific bioactive compounds within cranberries, standardize probiotic formulations, and establish comprehensive guidelines for their clinical use in UTI management.